News

A federal appeals court has upheld a lower court’s decision to restrict abortion pill sales in West Virginia. A three-judge ...
Merck MRK recently launched two late-stage clinical studies to evaluate MK-8527, its investigational once-monthly oral pill for HIV pre-exposure prophylaxis (PrEP). The EXPrESSIVE-11 study, which ...
PillTrek is a mini capsule that senses gut biomarkers in real time. It enables advanced GI diagnostics without invasive ...
This new FDA-approved shot is designed to break down the barriers that have kept too many people from accessing PrEP.
Merck MRK announced that the FDA has accepted for review the new drug application (“NDA”) seeking approval for its investigational, once-daily, oral, two-drug, single-tablet regimen of ...